When the omicron variant of COVID-19 was first identified in South Africa, the country’s scientists were quick to inform global health leaders of the new mutations they had found.
Although scientists have little information about the new variant and aren’t certain where it originated, several countries, including the United States, Canada, the United Kingdom and the European Union announced almost immediate travel bans from South Africa and other southern African nations.
As the week began, Japan followed suit with far more restrictive measures.
Japanese Prime Minister Fumio Kishida announced Monday the decision to reestablish entry rules for foreign travelers to limit any potential spread of the omicron variant. This comes just weeks after the country reopened its borders on Nov. 8.
Kishida told reporters this step is a “temporary measure until information about the omicron variant becomes clear.”
Israel also implemented a blanket ban to all foreigners Sunday night after initial establishing restrictions on travelers just from southern African countries. According to The Jerusalem Postunder this new policy anyone returning from any country — vaccination Israelis included — will need to isolate for three days once in the country.
“There is very little utility of these kinds of bans,” Saad Omer, director of the Yale Institute of Global Health, told NPR.
“Unfortunately, from what we know about the epidemiology of SARS-CoV-2 and the epidemiology of this variant, the horse has probably left the barn,” Omer said, noting the high transmissibility of this coronavirus and its variants.
And even the omicron variant has been reported in several other countries in Europe, Asia and North America though, travel bans are significantly being imposed on southern African countries.
One of the identified cases of the omicron variant in Belgium had no contact or travel with any nations in southern Africa, suggestive community spread could already be taking place.
“If the question is to prevent the variant from coming in, it really doesn’t make sense to exempt countries where it has been identified and that has even more direct flights than southern Africa,” Omer said.
Studies show travel bans are ineffective at curbing the spread of disease
Travel bans from start of the COVID-19 pandemic resulting in economic and other consequences were still seeing today.
A recent study from the journal Science shows that restricting international travel in the beginning stages of the COVID-19 pandemic did have some effect on delaying spread, but the researchers said restricting travel is only truly effective when paired with curbing the spread of infection through hand-washing, isolation and early detection .
Another study, in the Journal of Emergency Management, concluded that little evidence exists to prove that international travel bans are effective in controlling the spread of infectious disease, and such measures should only be taken if recommended by the World Health Organization. With the omicron variant, the WHO has already cautioned against imposing travel bans.
Dr. Margaret Harris, a public health doctor and a talk for the World Health Organization, told NPR’s Morning Edition that the restrictions do give countries some “breathing space” in their early responses to omicron.
She concerned governments to “make the most of that time. Build up your hospital capacity, build up your tracking and tracing, build up your surveillance, prepare.”
However, introducing a travel ban can give a false sense that the virus is being contained, researchers said, adding that such policies can also make it difficult to transport health care workers and other resources.
Additionally, the stigma of travel bans can exculpate racism and xenophobia, according to Nicole Errett of the University of Washington, who was the lead author on the Journal of Emergency Management study.
Travel bans could lead to less scientific transparency
Omer, of the Yale Institute of Global Health, has another concern about implementing travel bans during a public health crisis: It can dampen the commitment to scientific transparency.
When countries that are proactive about disclosing the circulation of a virus are hit with travel restrictions, he said, that undercuts the case for health officials to be upcoming about what’s happening in their countries.
“You don’t want a situation where, a month from now, a country health minister … gets a result of sequenced virus and they say, ‘OK, if it is that widespread, it’s going to come out anyways from some other country, why be the first one?’ And that cycle starts,” said Omer.
Addressing vaccine inequity around the world is the best way to stop these new variants from emerging, Omer said.
“If there are more transmission events going on with every hour, with every day, with every week, the likelihood of a variant emerging goes up,” he said.
And one of the most effective ways to address inequity, Omer said, is to allow for all regions, low-income countries in particular, to produce their own vaccines.
It’s too early to tell whether the omicron variant in particular will become a serious public health threat, Omer added, “but that doesn’t mean that we are not playing with fire by letting vaccine inequity continue.”